201 related articles for article (PubMed ID: 15101356)
1. Ephedra ban: no shortage of reasons.
Rados C
FDA Consum; 2004; 38(2):6-7. PubMed ID: 15101356
[TBL] [Abstract][Full Text] [Related]
2. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 Feb; 69(28):6787-854. PubMed ID: 14968803
[TBL] [Abstract][Full Text] [Related]
3. FDA v. ephedra: is it time to lift the ban?
Pyle KR
Food Drug Law J; 2006; 61(4):701-51. PubMed ID: 17180770
[No Abstract] [Full Text] [Related]
4. Ephedra: once a boon, now a bane.
Scheindlin S
Mol Interv; 2003 Oct; 3(7):358-60. PubMed ID: 14993455
[No Abstract] [Full Text] [Related]
5. Ephedra: heart dangers in disguise.
Consum Rep; 2004 Jan; 69(1):22-3. PubMed ID: 14677546
[No Abstract] [Full Text] [Related]
6. Working to get ephedra banned.
Consum Rep; 2003 Feb; 68(2):6. PubMed ID: 12516584
[No Abstract] [Full Text] [Related]
7. Dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk; final rule.
Food and Drug Administration, Public Health Service, U.S. Department of Health and Human Services
J Pain Palliat Care Pharmacother; 2004; 18(3):95-107. PubMed ID: 15364637
[TBL] [Abstract][Full Text] [Related]
8. FDA issues alert on ephedra supplements in the USA.
Nelson R
Lancet; 2004 Jan; 363(9403):135. PubMed ID: 14733193
[No Abstract] [Full Text] [Related]
9. Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.
Seamon MJ; Clauson KA
J Herb Pharmacother; 2005; 5(3):67-86. PubMed ID: 16520299
[TBL] [Abstract][Full Text] [Related]
10. Ephedra banned.
Cockey CD
AWHONN Lifelines; 2004; 8(1):19-25. PubMed ID: 15031882
[No Abstract] [Full Text] [Related]
11. Medicine. Ephedra--scientific evidence versus money/politics.
Wolfe SM
Science; 2003 Apr; 300(5618):437. PubMed ID: 12702860
[No Abstract] [Full Text] [Related]
12. [Case of intractable ventricula fibrillation by a multicomponent dietary supplement containing ephedra and caffeine overdose].
Takeuchi S; Homma M; Inoue J; Kato H; Murata K; Ogasawara T
Chudoku Kenkyu; 2007 Jul; 20(3):269-71. PubMed ID: 17784561
[TBL] [Abstract][Full Text] [Related]
13. HHS to study ephedra, step up enforcement against illegal marketing.
FDA Consum; 2002; 36(5):3. PubMed ID: 12412534
[No Abstract] [Full Text] [Related]
14. Banning ephedra: good call, poor vision.
Gordon JS
Altern Ther Health Med; 2004; 10(6):18-9. PubMed ID: 15624346
[No Abstract] [Full Text] [Related]
15. Beyond ephedra. Why the FDA's ban may lead users to look for other weight-loss stimulants.
Gupta S
Time; 2004 Jan; 163(2):78. PubMed ID: 14735657
[No Abstract] [Full Text] [Related]
16. Adverse events associated with supplements containing ephedra alkaloids.
Geiger JD
Clin J Sport Med; 2002 Jul; 12(4):263. PubMed ID: 12150162
[No Abstract] [Full Text] [Related]
17. Cardiovascular effects of ephedra alkaloids: a comprehensive review.
Andraws R; Chawla P; Brown DL
Prog Cardiovasc Dis; 2005; 47(4):217-25. PubMed ID: 15991150
[TBL] [Abstract][Full Text] [Related]
18. FDA to ban sales of dietary supplements containing ephedra.
Ling AM
J Law Med Ethics; 2004; 32(1):184-6. PubMed ID: 15152444
[No Abstract] [Full Text] [Related]
19. "Tag--we're it".
Czap A
Altern Med Rev; 2003 May; 8(2):104. PubMed ID: 12777156
[No Abstract] [Full Text] [Related]
20. Ergogenic aids: an update on ephedra.
Keisler BD; Hosey RG
Curr Sports Med Rep; 2005 Aug; 4(4):231-5. PubMed ID: 16004835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
